List of Tables
    Table 1. Chimeric Antigen Receptor T Cell Therapy Market Opportunities & Trends in Global Market
    Table 2. Chimeric Antigen Receptor T Cell Therapy Market Drivers in Global Market
    Table 3. Chimeric Antigen Receptor T Cell Therapy Market Restraints in Global Market
    Table 4. Key Players of Chimeric Antigen Receptor T Cell Therapy in Global Market
    Table 5. Top Chimeric Antigen Receptor T Cell Therapy Players in Global Market, Ranking by Revenue (2021)
    Table 6. Global Chimeric Antigen Receptor T Cell Therapy Revenue by Companies, (US$, Mn), 2017-2022
    Table 7. Global Chimeric Antigen Receptor T Cell Therapy Revenue Share by Companies, 2017-2022
    Table 8. Global Companies Chimeric Antigen Receptor T Cell Therapy Product Type
    Table 9. List of Global Tier 1 Chimeric Antigen Receptor T Cell Therapy Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 10. List of Global Tier 2 and Tier 3 Chimeric Antigen Receptor T Cell Therapy Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 11. By Type – Global Chimeric Antigen Receptor T Cell Therapy Revenue, (US$, Mn), 2021 & 2028
    Table 12. By Type - Chimeric Antigen Receptor T Cell Therapy Revenue in Global (US$, Mn), 2017-2022
    Table 13. By Type - Chimeric Antigen Receptor T Cell Therapy Revenue in Global (US$, Mn), 2023-2028
    Table 14. By Application – Global Chimeric Antigen Receptor T Cell Therapy Revenue, (US$, Mn), 2021 & 2028
    Table 15. By Application - Chimeric Antigen Receptor T Cell Therapy Revenue in Global (US$, Mn), 2017-2022
    Table 16. By Application - Chimeric Antigen Receptor T Cell Therapy Revenue in Global (US$, Mn), 2023-2028
    Table 17. By Region – Global Chimeric Antigen Receptor T Cell Therapy Revenue, (US$, Mn), 2021 & 2028
    Table 18. By Region - Global Chimeric Antigen Receptor T Cell Therapy Revenue (US$, Mn), 2017-2022
    Table 19. By Region - Global Chimeric Antigen Receptor T Cell Therapy Revenue (US$, Mn), 2023-2028
    Table 20. By Country - North America Chimeric Antigen Receptor T Cell Therapy Revenue, (US$, Mn), 2017-2022
    Table 21. By Country - North America Chimeric Antigen Receptor T Cell Therapy Revenue, (US$, Mn), 2023-2028
    Table 22. By Country - Europe Chimeric Antigen Receptor T Cell Therapy Revenue, (US$, Mn), 2017-2022
    Table 23. By Country - Europe Chimeric Antigen Receptor T Cell Therapy Revenue, (US$, Mn), 2023-2028
    Table 24. By Region - Asia Chimeric Antigen Receptor T Cell Therapy Revenue, (US$, Mn), 2017-2022
    Table 25. By Region - Asia Chimeric Antigen Receptor T Cell Therapy Revenue, (US$, Mn), 2023-2028
    Table 26. By Country - South America Chimeric Antigen Receptor T Cell Therapy Revenue, (US$, Mn), 2017-2022
    Table 27. By Country - South America Chimeric Antigen Receptor T Cell Therapy Revenue, (US$, Mn), 2023-2028
    Table 28. By Country - Middle East & Africa Chimeric Antigen Receptor T Cell Therapy Revenue, (US$, Mn), 2017-2022
    Table 29. By Country - Middle East & Africa Chimeric Antigen Receptor T Cell Therapy Revenue, (US$, Mn), 2023-2028
    Table 30. Amgen Corporate Summary
    Table 31. Amgen Chimeric Antigen Receptor T Cell Therapy Product Offerings
    Table 32. Amgen Chimeric Antigen Receptor T Cell Therapy Revenue (US$, Mn), (2017-2022)
    Table 33. Bellicum Pharmaceuticals Corporate Summary
    Table 34. Bellicum Pharmaceuticals Chimeric Antigen Receptor T Cell Therapy Product Offerings
    Table 35. Bellicum Pharmaceuticals Chimeric Antigen Receptor T Cell Therapy Revenue (US$, Mn), (2017-2022)
    Table 36. Bluebird Bio Corporate Summary
    Table 37. Bluebird Bio Chimeric Antigen Receptor T Cell Therapy Product Offerings
    Table 38. Bluebird Bio Chimeric Antigen Receptor T Cell Therapy Revenue (US$, Mn), (2017-2022)
    Table 39. Caribou Biosciences Corporate Summary
    Table 40. Caribou Biosciences Chimeric Antigen Receptor T Cell Therapy Product Offerings
    Table 41. Caribou Biosciences Chimeric Antigen Receptor T Cell Therapy Revenue (US$, Mn), (2017-2022)
    Table 42. Celgene Corporation Corporate Summary
    Table 43. Celgene Corporation Chimeric Antigen Receptor T Cell Therapy Product Offerings
    Table 44. Celgene Corporation Chimeric Antigen Receptor T Cell Therapy Revenue (US$, Mn), (2017-2022)
    Table 45. Cellectis Corporate Summary
    Table 46. Cellectis Chimeric Antigen Receptor T Cell Therapy Product Offerings
    Table 47. Cellectis Chimeric Antigen Receptor T Cell Therapy Revenue (US$, Mn), (2017-2022)
    Table 48. Celyad Oncology Corporate Summary
    Table 49. Celyad Oncology Chimeric Antigen Receptor T Cell Therapy Product Offerings
    Table 50. Celyad Oncology Chimeric Antigen Receptor T Cell Therapy Revenue (US$, Mn), (2017-2022)
    Table 51. Gilead Sciences Corporate Summary
    Table 52. Gilead Sciences Chimeric Antigen Receptor T Cell Therapy Product Offerings
    Table 53. Gilead Sciences Chimeric Antigen Receptor T Cell Therapy Revenue (US$, Mn), (2017-2022)
    Table 54. Intellia Therapeutics Corporate Summary
    Table 55. Intellia Therapeutics Chimeric Antigen Receptor T Cell Therapy Product Offerings
    Table 56. Intellia Therapeutics Chimeric Antigen Receptor T Cell Therapy Revenue (US$, Mn), (2017-2022)
    Table 57. Johnson & Johnson Corporate Summary
    Table 58. Johnson & Johnson Chimeric Antigen Receptor T Cell Therapy Product Offerings
    Table 59. Johnson & Johnson Chimeric Antigen Receptor T Cell Therapy Revenue (US$, Mn), (2017-2022)
    Table 60. Legend Biotech Corporate Summary
    Table 61. Legend Biotech Chimeric Antigen Receptor T Cell Therapy Product Offerings
    Table 62. Legend Biotech Chimeric Antigen Receptor T Cell Therapy Revenue (US$, Mn), (2017-2022)
    Table 63. Merck Corporate Summary
    Table 64. Merck Chimeric Antigen Receptor T Cell Therapy Product Offerings
    Table 65. Merck Chimeric Antigen Receptor T Cell Therapy Revenue (US$, Mn), (2017-2022)
    Table 66. Noile-Immune Biotech Corporate Summary
    Table 67. Noile-Immune Biotech Chimeric Antigen Receptor T Cell Therapy Product Offerings
    Table 68. Noile-Immune Biotech Chimeric Antigen Receptor T Cell Therapy Revenue (US$, Mn), (2017-2022)
    Table 69. Novartis Corporate Summary
    Table 70. Novartis Chimeric Antigen Receptor T Cell Therapy Product Offerings
    Table 71. Novartis Chimeric Antigen Receptor T Cell Therapy Revenue (US$, Mn), (2017-2022)
    Table 72. Pfizer Corporate Summary
    Table 73. Pfizer Chimeric Antigen Receptor T Cell Therapy Product Offerings
    Table 74. Pfizer Chimeric Antigen Receptor T Cell Therapy Revenue (US$, Mn), (2017-2022)
    Table 75. Sangamo Therapeutics Corporate Summary
    Table 76. Sangamo Therapeutics Chimeric Antigen Receptor T Cell Therapy Product Offerings
    Table 77. Sangamo Therapeutics Chimeric Antigen Receptor T Cell Therapy Revenue (US$, Mn), (2017-2022)
    Table 78. Servier Laboratories Corporate Summary
    Table 79. Servier Laboratories Chimeric Antigen Receptor T Cell Therapy Product Offerings
    Table 80. Servier Laboratories Chimeric Antigen Receptor T Cell Therapy Revenue (US$, Mn), (2017-2022)
List of Figures
    Figure 1. Chimeric Antigen Receptor T Cell Therapy Segment by Type in 2021
    Figure 2. Chimeric Antigen Receptor T Cell Therapy Segment by Application in 2021
    Figure 3. Global Chimeric Antigen Receptor T Cell Therapy Market Overview: 2021
    Figure 4. Key Caveats
    Figure 5. Global Chimeric Antigen Receptor T Cell Therapy Market Size: 2021 VS 2028 (US$, Mn)
    Figure 6. Global Chimeric Antigen Receptor T Cell Therapy Revenue, 2017-2028 (US$, Mn)
    Figure 7. The Top 3 and 5 Players Market Share by Chimeric Antigen Receptor T Cell Therapy Revenue in 2021
    Figure 8. By Type - Global Chimeric Antigen Receptor T Cell Therapy Revenue Market Share, 2017-2028
    Figure 9. By Application - Global Chimeric Antigen Receptor T Cell Therapy Revenue Market Share, 2017-2028
    Figure 10. By Region - Global Chimeric Antigen Receptor T Cell Therapy Revenue Market Share, 2017-2028
    Figure 11. By Country - North America Chimeric Antigen Receptor T Cell Therapy Revenue Market Share, 2017-2028
    Figure 12. US Chimeric Antigen Receptor T Cell Therapy Revenue, (US$, Mn), 2017-2028
    Figure 13. Canada Chimeric Antigen Receptor T Cell Therapy Revenue, (US$, Mn), 2017-2028
    Figure 14. Mexico Chimeric Antigen Receptor T Cell Therapy Revenue, (US$, Mn), 2017-2028
    Figure 15. By Country - Europe Chimeric Antigen Receptor T Cell Therapy Revenue Market Share, 2017-2028
    Figure 16. Germany Chimeric Antigen Receptor T Cell Therapy Revenue, (US$, Mn), 2017-2028
    Figure 17. France Chimeric Antigen Receptor T Cell Therapy Revenue, (US$, Mn), 2017-2028
    Figure 18. U.K. Chimeric Antigen Receptor T Cell Therapy Revenue, (US$, Mn), 2017-2028
    Figure 19. Italy Chimeric Antigen Receptor T Cell Therapy Revenue, (US$, Mn), 2017-2028
    Figure 20. Russia Chimeric Antigen Receptor T Cell Therapy Revenue, (US$, Mn), 2017-2028
    Figure 21. Nordic Countries Chimeric Antigen Receptor T Cell Therapy Revenue, (US$, Mn), 2017-2028
    Figure 22. Benelux Chimeric Antigen Receptor T Cell Therapy Revenue, (US$, Mn), 2017-2028
    Figure 23. By Region - Asia Chimeric Antigen Receptor T Cell Therapy Revenue Market Share, 2017-2028
    Figure 24. China Chimeric Antigen Receptor T Cell Therapy Revenue, (US$, Mn), 2017-2028
    Figure 25. Japan Chimeric Antigen Receptor T Cell Therapy Revenue, (US$, Mn), 2017-2028
    Figure 26. South Korea Chimeric Antigen Receptor T Cell Therapy Revenue, (US$, Mn), 2017-2028
    Figure 27. Southeast Asia Chimeric Antigen Receptor T Cell Therapy Revenue, (US$, Mn), 2017-2028
    Figure 28. India Chimeric Antigen Receptor T Cell Therapy Revenue, (US$, Mn), 2017-2028
    Figure 29. By Country - South America Chimeric Antigen Receptor T Cell Therapy Revenue Market Share, 2017-2028
    Figure 30. Brazil Chimeric Antigen Receptor T Cell Therapy Revenue, (US$, Mn), 2017-2028
    Figure 31. Argentina Chimeric Antigen Receptor T Cell Therapy Revenue, (US$, Mn), 2017-2028
    Figure 32. By Country - Middle East & Africa Chimeric Antigen Receptor T Cell Therapy Revenue Market Share, 2017-2028
    Figure 33. Turkey Chimeric Antigen Receptor T Cell Therapy Revenue, (US$, Mn), 2017-2028
    Figure 34. Israel Chimeric Antigen Receptor T Cell Therapy Revenue, (US$, Mn), 2017-2028
    Figure 35. Saudi Arabia Chimeric Antigen Receptor T Cell Therapy Revenue, (US$, Mn), 2017-2028
    Figure 36. UAE Chimeric Antigen Receptor T Cell Therapy Revenue, (US$, Mn), 2017-2028
    Figure 37. Amgen Chimeric Antigen Receptor T Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 38. Bellicum Pharmaceuticals Chimeric Antigen Receptor T Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 39. Bluebird Bio Chimeric Antigen Receptor T Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 40. Caribou Biosciences Chimeric Antigen Receptor T Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 41. Celgene Corporation Chimeric Antigen Receptor T Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 42. Cellectis Chimeric Antigen Receptor T Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 43. Celyad Oncology Chimeric Antigen Receptor T Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 44. Gilead Sciences Chimeric Antigen Receptor T Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 45. Intellia Therapeutics Chimeric Antigen Receptor T Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 46. Johnson & Johnson Chimeric Antigen Receptor T Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 47. Legend Biotech Chimeric Antigen Receptor T Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 48. Merck Chimeric Antigen Receptor T Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 49. Noile-Immune Biotech Chimeric Antigen Receptor T Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 50. Novartis Chimeric Antigen Receptor T Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 51. Pfizer Chimeric Antigen Receptor T Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 52. Sangamo Therapeutics Chimeric Antigen Receptor T Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 53. Servier Laboratories Chimeric Antigen Receptor T Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)